Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M, Sanmartín JL, Fernández-García A, Cruz I, Fernández de Larrea N, Molina M, Rodríguez-Cabrera F, Martín M, Merino-Amador P, León Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R; ENE-COVID Study Group. Pollán M, et al. Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6. Lancet. 2020. PMID: 32645347 Free PMC article.
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
Díez-Fuertes F, Iglesias-Caballero M, García-Pérez J, Monzón S, Jiménez P, Varona S, Cuesta I, Zaballos Á, Jiménez M, Checa L, Pozo F, Pérez-Olmeda M, Thomson MM, Alcamí J, Casas I. Díez-Fuertes F, et al. J Virol. 2021 Jan 13;95(3):e01583-20. doi: 10.1128/JVI.01583-20. Print 2021 Jan 13. J Virol. 2021. PMID: 33127745 Free PMC article.
SARS-CoV-2 seroprevalence in Spain - Authors' reply.
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Pérez-Olmeda M, Yotti R; ENE-COVID Study Group. Pollán M, et al. Lancet. 2020 Nov 7;396(10261):1484-1485. doi: 10.1016/S0140-6736(20)32266-2. Lancet. 2020. PMID: 33160561 Free PMC article. No abstract available.
Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study.
Pastor-Barriuso R, Pérez-Gómez B, Hernán MA, Pérez-Olmeda M, Yotti R, Oteo-Iglesias J, Sanmartín JL, León-Gómez I, Fernández-García A, Fernández-Navarro P, Cruz I, Martín M, Delgado-Sanz C, Fernández de Larrea N, León Paniagua J, Muñoz-Montalvo JF, Blanco F, Larrauri A, Pollán M; ENE-COVID Study Group. Pastor-Barriuso R, et al. BMJ. 2020 Nov 27;371:m4509. doi: 10.1136/bmj.m4509. BMJ. 2020. PMID: 33246972 Free PMC article.
ENE-COVID nationwide serosurvey served to characterize asymptomatic infections and to develop a symptom-based risk score to predict COVID-19.
Pérez-Gómez B, Pastor-Barriuso R, Pérez-Olmeda M, Hernán MA, Oteo-Iglesias J, Fernández de Larrea N, Fernández-García A, Martín M, Fernández-Navarro P, Cruz I, Sanmartín JL, León Paniagua J, Muñoz-Montalvo JF, Blanco F, Yotti R, Pollán M; ENE-COVID Study Group. Pérez-Gómez B, et al. J Clin Epidemiol. 2021 Nov;139:240-254. doi: 10.1016/j.jclinepi.2021.06.005. Epub 2021 Jun 11. J Clin Epidemiol. 2021. PMID: 34126206 Free PMC article.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals.
Lozano-Ojalvo D, Camara C, Lopez-Granados E, Nozal P, Del Pino-Molina L, Bravo-Gallego LY, Paz-Artal E, Pion M, Correa-Rocha R, Ortiz A, Lopez-Hoyos M, Iribarren ME, Portoles J, Rojo-Portoles MP, Ojeda G, Cervera I, Gonzalez-Perez M, Bodega-Mayor I, Montes-Casado M, Portoles P, Perez-Olmeda M, Oteo J, Sanchez-Tarjuelo R, Pothula V, Schwarz M, Brahmachary M, Tan AT, Le Bert N, Berin C, Bertoletti A, Guccione E, Ochando J. Lozano-Ojalvo D, et al. Cell Rep. 2021 Aug 24;36(8):109570. doi: 10.1016/j.celrep.2021.109570. Epub 2021 Aug 4. Cell Rep. 2021. PMID: 34390647 Free PMC article.
Comparative evaluation of assays for IgM detection of rubella and measles infections.
Pérez Olmeda M, Balfagón P, Camacho J, Dafouz D, de la Fuente J, Murillo MÁ, Muñoz JL, Fernández García A, Sanz JC, de Ory F. Pérez Olmeda M, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jan;40(1):22-27. doi: 10.1016/j.eimce.2020.06.020. Enferm Infecc Microbiol Clin (Engl Ed). 2022. PMID: 34991849
87 results